Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 3940908)

Published in Diabetes on January 01, 1986

Authors

C Bogardus, M R Taskinen, J Zawadzki, S Lillioja, D Mott, B V Howard

Articles by these authors

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care (1997) 23.95

Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care (2001) 14.03

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet (2005) 13.18

Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1999) 8.04

The Sleep Heart Health Study: design, rationale, and methods. Sleep (1997) 7.55

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest (1999) 7.35

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med (1993) 6.89

Changing habits to delay diabetes. N Engl J Med (2001) 5.30

Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber. J Clin Invest (1986) 5.18

The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol (1990) 4.89

Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes (1997) 4.17

Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol (2000) 3.87

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia (2000) 3.63

Impact of diabetes on cardiac structure and function: the strong heart study. Circulation (2000) 3.56

Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med (1988) 3.41

Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med (1988) 3.19

Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol (1990) 3.01

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation (1998) 2.97

Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest (1987) 2.96

Dietary protein and weight reduction: a statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation (2001) 2.71

Obesity and insulin resistance: lessons learned from the Pima Indians. Diabetes Metab Rev (1988) 2.64

Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest (1990) 2.63

Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest (1984) 2.62

Cardiovascular disease risk factors among American Indians. The Strong Heart Study. Am J Epidemiol (1995) 2.53

AHA Science Advisory: Lyon Diet Heart Study. Benefits of a Mediterranean-style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease. Circulation (2001) 2.51

All-cause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988. The Strong Heart Study. Am J Epidemiol (1998) 2.43

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes (1999) 2.36

Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes (1996) 2.33

Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care (2001) 2.33

Diabetes and impaired glucose tolerance in three American Indian populations aged 45-74 years. The Strong Heart Study. Diabetes Care (1995) 2.26

An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J Clin Invest (1998) 2.18

Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators. Circulation (1998) 2.14

Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study. Circulation (2000) 2.10

Microarray profiling of skeletal muscle tissues from equally obese, non-diabetic insulin-sensitive and insulin-resistant Pima Indians. Diabetologia (2002) 2.08

Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia (2005) 2.03

Energy metabolism in African Americans: potential risk factors for obesity. Am J Clin Nutr (1999) 2.03

Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. J Clin Invest (1984) 2.03

Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest (1991) 2.02

Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med (1995) 1.99

Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes (1999) 1.98

Relationship of genetics, age, and physical fitness to daily energy expenditure and fuel utilization. Am J Clin Nutr (1989) 1.96

Familial dependence of the resting metabolic rate. N Engl J Med (1986) 1.94

Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association. Circulation (1996) 1.91

Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes (2000) 1.90

Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group. Circulation (1997) 1.89

Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res (2001) 1.89

Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol (1985) 1.89

A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest (2000) 1.85

Body weight gain in free-living Pima Indians: effect of energy intake vs expenditure. Int J Obes Relat Metab Disord (2003) 1.79

Autosomal genomic scan for loci linked to obesity and energy metabolism in Pima Indians. Am J Hum Genet (1998) 1.78

Prevalence and correlates of mitral valve prolapse in a population-based sample of American Indians: the Strong Heart Study. Am J Med (2001) 1.78

Obesity in the Pima Indians: its magnitude and relationship with diabetes. Am J Clin Nutr (1991) 1.77

The uptake of SV40 DNA by nonpermissive cells in the presence of DEAE-dextran. Biochim Biophys Acta (1971) 1.76

Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care (2000) 1.76

A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes (2000) 1.73

Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am J Cardiol (2000) 1.71

A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia (1995) 1.70

In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes (1987) 1.70

Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med (1991) 1.68

Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the Strong Heart Study. Circulation (1997) 1.66

Serum complement and familial combined hyperlipidemia. Atherosclerosis (1997) 1.64

Phytochemicals and cardiovascular disease. A statement for healthcare professionals from the American Heart Association. Circulation (1997) 1.60

Characterization of the collagen synthesized by endothelial cells in culture. Proc Natl Acad Sci U S A (1976) 1.58

Lipoprotein metabolism in diabetes mellitus. J Lipid Res (1987) 1.58

The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol (2001) 1.55

Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N Engl J Med (1990) 1.54

Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Arterioscler Thromb Vasc Biol (1997) 1.53

Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat Genet (1998) 1.52

The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia (2001) 1.51

An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest (1995) 1.51

Determinants of energy expenditure and fuel utilization in man: effects of body composition, age, sex, ethnicity and glucose tolerance in 916 subjects. Int J Obes Relat Metab Disord (1999) 1.51

Energy expenditure, fat oxidation, and body weight regulation: a study of metabolic adaptation to long-term weight change. J Clin Endocrinol Metab (2000) 1.49

Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia (1997) 1.49

Lipid intolerance in smokers. J Intern Med (1995) 1.48

Effect of muscular exercise on insulin secretion. Diabetes (1968) 1.48

Analysis of MGEA5 on 10q24.1-q24.3 encoding the beta-O-linked N-acetylglucosaminidase as a candidate gene for type 2 diabetes mellitus in Pima Indians. Mol Genet Metab (2002) 1.48

Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima Indians. Diabetologia (2005) 1.47

Relationship between insulin-mediated glucose disposal and lipid metabolism in man. J Clin Invest (1985) 1.44